SPRR2E
geneOn this page
Summary
SPRR2E (small proline rich protein 2E, HGNC:11265) is a protein-coding gene on chromosome 1q21.3, encoding Small proline-rich protein 2E (P22531). Cross-linked envelope protein of keratinocytes.
This gene encodes a member of a family of small proline-rich proteins clustered in the epidermal differentiation complex on chromosome 1q21. The encoded protein, along with other family members, is a component of the cornified cell envelope that forms beneath the plasma membrane in terminally differentiated stratified squamous epithelia. This envelope serves as a barrier against extracellular and environmental factors. The seven SPRR2 genes (A-G) appear to have been homogenized by gene conversion compared to others in the cluster that exhibit greater differences in protein structure.
Source: NCBI Gene 6704 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_001024209
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11265 |
| Approved symbol | SPRR2E |
| Name | small proline rich protein 2E |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000203785 |
| Ensembl biotype | protein_coding |
| OMIM | 617588 |
| Entrez | 6704 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000368750, ENST00000368751
RefSeq mRNA: 1 — MANE Select: NM_001024209
NM_001024209
CCDS: CCDS30866
Canonical transcript exons
ENST00000368750 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001447895 | 153093135 | 153093770 |
| ENSE00001596930 | 153094484 | 153094526 |
Expression profiles
Bgee: expression breadth ubiquitous, 114 present calls, max score 99.36.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.7193 / max 1413.8380, expressed in 58 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14588 | 1.7193 | 58 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 99.36 | gold quality |
| skin of leg | UBERON:0001511 | 98.34 | gold quality |
| zone of skin | UBERON:0000014 | 98.04 | gold quality |
| esophagus mucosa | UBERON:0002469 | 97.78 | gold quality |
| skin of abdomen | UBERON:0001416 | 97.59 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.83 | silver quality |
| esophagus | UBERON:0001043 | 81.62 | gold quality |
| vagina | UBERON:0000996 | 81.11 | gold quality |
| minor salivary gland | UBERON:0001830 | 72.87 | gold quality |
| ectocervix | UBERON:0012249 | 72.13 | gold quality |
| tonsil | UBERON:0002372 | 72.00 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 69.34 | gold quality |
| right coronary artery | UBERON:0001625 | 67.85 | gold quality |
| uterine cervix | UBERON:0000002 | 65.42 | gold quality |
| ovary | UBERON:0000992 | 65.17 | gold quality |
| left ovary | UBERON:0002119 | 65.14 | gold quality |
| lower esophagus | UBERON:0013473 | 63.48 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 63.43 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 62.08 | gold quality |
| gastrocnemius | UBERON:0001388 | 62.07 | gold quality |
| right ovary | UBERON:0002118 | 61.77 | gold quality |
| heart left ventricle | UBERON:0002084 | 60.03 | gold quality |
| right lobe of liver | UBERON:0001114 | 59.35 | gold quality |
| body of pancreas | UBERON:0001150 | 59.07 | gold quality |
| right atrium auricular region | UBERON:0006631 | 58.62 | gold quality |
| body of stomach | UBERON:0001161 | 58.44 | gold quality |
| fundus of stomach | UBERON:0001160 | 58.20 | gold quality |
| omental fat pad | UBERON:0010414 | 58.05 | gold quality |
| tibial artery | UBERON:0007610 | 57.67 | gold quality |
| popliteal artery | UBERON:0002250 | 57.64 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-1 | yes | 6905.99 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting SPRR2E, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-892A | 99.54 | 68.16 | 1141 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-892C-5P | 99.16 | 70.56 | 2116 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-501-5P | 98.77 | 68.88 | 1328 |
| HSA-MIR-6754-5P | 98.60 | 65.54 | 1627 |
| HSA-MIR-7114-5P | 98.51 | 67.87 | 1349 |
| HSA-MIR-211-3P | 98.14 | 66.77 | 1052 |
| HSA-MIR-506-5P | 98.02 | 67.41 | 1065 |
| HSA-MIR-3665 | 97.73 | 65.08 | 975 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-125A-3P | 97.04 | 66.92 | 902 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-4794 | 96.47 | 65.53 | 1063 |
| HSA-MIR-3690 | 96.44 | 65.18 | 737 |
| HSA-MIR-664A-5P | 95.84 | 64.93 | 949 |
Literature-anchored findings (GeneRIF, showing 1)
- Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families. (PMID:18643845)
Cross-species orthologs
0 orthologs
Paralogs (2): SPRR2D (ENSG00000163216), SPRR2B (ENSG00000196805)
Protein
Protein identifiers
Small proline-rich protein 2E — P22531 (reviewed: P22531)
Alternative names: Small proline-rich protein II
All UniProt accessions (1): P22531
UniProt curated annotations — full annotation on UniProt →
Function. Cross-linked envelope protein of keratinocytes. It is a keratinocyte protein that first appears in the cell cytosol, but ultimately becomes cross-linked to membrane proteins by transglutaminase. All that results in the formation of an insoluble envelope beneath the plasma membrane.
Subcellular location. Cytoplasm.
Induction. During squamous differentiation of epidermal keratinocytes.
Similarity. Belongs to the cornifin (SPRR) family.
RefSeq proteins (1): NP_001019380* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029142 | SPRR2 | Family |
Pfam: PF14820
UniProt features (10 total): repeat 3, region of interest 3, compositionally biased region 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P22531-F1 | 77.66 | 0.04 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-6805567 | Keratinization |
MSigDB gene sets: 30 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, CHANG_IMMORTALIZED_BY_HPV31_DN, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, chr1q21, GOCC_CORNIFIED_ENVELOPE, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, GOBP_CORNIFICATION, GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS, REACTOME_KERATINIZATION, REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE, GOBP_KERATINOCYTE_DIFFERENTIATION, GOBP_EPITHELIAL_CELL_DIFFERENTIATION
GO Biological Process (4): epidermis development (GO:0008544), cornification (GO:0070268), peptide cross-linking (GO:0018149), keratinization (GO:0031424)
GO Molecular Function (3): structural molecule activity (GO:0005198), structural constituent of skin epidermis (GO:0030280), protein binding (GO:0005515)
GO Cellular Component (3): cornified envelope (GO:0001533), cytoplasm (GO:0005737), cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Keratinization | 1 |
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| tissue development | 1 |
| programmed cell death | 1 |
| keratinization | 1 |
| cornified envelope assembly | 1 |
| protein modification process | 1 |
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| molecular_function | 1 |
| structural molecule activity | 1 |
| binding | 1 |
| plasma membrane | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
378 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPRR2E | SPRR2D | P22532 | 863 |
| SPRR2E | SPRR2G | Q9BYE4 | 775 |
| SPRR2E | SPRR1B | P22528 | 766 |
| SPRR2E | SPRR2F | Q96RM1 | 736 |
| SPRR2E | SPRR2A | P35326 | 728 |
| SPRR2E | LCE3E | Q5T5B0 | 620 |
| SPRR2E | LCE3D | Q9BYE3 | 609 |
| SPRR2E | SPRR3 | Q9UBC9 | 571 |
| SPRR2E | CNFN | Q9BYD5 | 542 |
| SPRR2E | LCE1C | Q5T751 | 528 |
| SPRR2E | SPRR1A | P35321 | 507 |
| SPRR2E | LCE2C | Q5TA81 | 506 |
| SPRR2E | LCE2A | Q5TA79 | 480 |
| SPRR2E | LCE3A | Q5TA76 | 471 |
| SPRR2E | SPRR4 | Q96PI1 | 447 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CBX1 | ZNF292 | psi-mi:“MI:0914”(association) | 0.530 |
| RYK | PCDH7 | psi-mi:“MI:0914”(association) | 0.530 |
| Cdk1 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| Akap12 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| Retreg2 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| Them6 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| SPRR2E | ARID3C | psi-mi:“MI:0915”(physical association) | 0.400 |
| AP3B1 | psi-mi:“MI:0914”(association) | 0.350 | |
| TP53BP1 | BCKDK | psi-mi:“MI:0914”(association) | 0.350 |
| WRAP73 | GGCT | psi-mi:“MI:0914”(association) | 0.350 |
| DDR2 | PLD2 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| CCR1 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| OPG065 | TUBB8B | psi-mi:“MI:0914”(association) | 0.350 |
| RASSF2 | SPRR2E | psi-mi:“MI:0914”(association) | 0.350 |
| RASSF9 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| RASSF10 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| E2F6 | GLUD1 | psi-mi:“MI:0914”(association) | 0.350 |
| SUV39H2 | ARG1 | psi-mi:“MI:0914”(association) | 0.350 |
| FHIP2B | VWA8 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (33): SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), S100A9 (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS), SPRR2E (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTR4, A6QNZ4, O14633, O70554, O70555, O70556, O70557, O70558, O70559, O70560, O70562, P15265, P22528, P22531, P22532, P35321, P35322, P35323, P35324, P35325, P35326, P49901, Q28658, Q32L04, Q4KL71, Q4R956, Q5T5B0, Q5T750, Q5T752, Q5T754, Q5T870, Q5T871, Q5TA76, Q5TA77, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q62266
Diamond homologs: O70554, O70555, O70556, O70557, O70558, O70559, O70560, O70562, P22531, P22532, P35325, P35326, Q4KL71, Q96RM1, Q9BYE4, Q9CQK8, O70561
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
117 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:153093891:G:C | donor_gain | 1.0000 |
| 1:153093908:T:TA | donor_gain | 1.0000 |
| 1:153093770:TC:T | acceptor_loss | 0.9800 |
| 1:153093771:C:T | acceptor_loss | 0.9800 |
| 1:153093772:T:G | acceptor_loss | 0.9800 |
| 1:153093890:AGCT:A | donor_gain | 0.9800 |
| 1:153094479:CTCA:C | donor_loss | 0.9800 |
| 1:153094480:TCACC:T | donor_loss | 0.9800 |
| 1:153094481:CAC:C | donor_loss | 0.9800 |
| 1:153094482:A:T | donor_loss | 0.9800 |
| 1:153094483:C:CT | donor_loss | 0.9800 |
| 1:153093771:C:CC | acceptor_gain | 0.9700 |
| 1:153094478:ACT:A | donor_loss | 0.9700 |
| 1:153094482:A:AC | donor_gain | 0.9700 |
| 1:153094483:C:CC | donor_gain | 0.9700 |
| 1:153094477:GACT:G | donor_loss | 0.9600 |
| 1:153094483:CCAG:C | donor_gain | 0.9500 |
| 1:153094483:CCA:C | donor_gain | 0.9400 |
| 1:153094482:AC:A | donor_gain | 0.8900 |
| 1:153094483:CC:C | donor_gain | 0.8900 |
| 1:153094483:CCAGG:C | donor_gain | 0.8900 |
| 1:153093769:AT:A | acceptor_gain | 0.8800 |
| 1:153093890:A:AC | donor_gain | 0.8800 |
| 1:153093766:AGAAT:A | acceptor_gain | 0.8600 |
| 1:153093773:G:C | acceptor_loss | 0.8600 |
| 1:153094370:TAAG:T | donor_gain | 0.8400 |
| 1:153094476:AGAC:A | donor_loss | 0.8400 |
| 1:153093767:GAAT:G | acceptor_gain | 0.8300 |
| 1:153093764:TCAGA:T | acceptor_gain | 0.8200 |
| 1:153093895:T:A | donor_gain | 0.8100 |
AlphaMissense
463 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:153093718:A:G | C12R | 0.774 |
| 1:153093716:G:C | C12W | 0.704 |
| 1:153093730:A:G | C8R | 0.704 |
| 1:153093536:C:A | K72N | 0.686 |
| 1:153093536:C:G | K72N | 0.686 |
| 1:153093725:C:A | K9N | 0.686 |
| 1:153093725:C:G | K9N | 0.686 |
| 1:153093728:G:C | C8W | 0.681 |
| 1:153093717:C:G | C12S | 0.674 |
| 1:153093718:A:T | C12S | 0.674 |
| 1:153093700:A:G | C18R | 0.642 |
| 1:153093734:C:A | Q6H | 0.631 |
| 1:153093734:C:G | Q6H | 0.631 |
| 1:153093671:A:C | C27W | 0.620 |
| 1:153093646:A:G | C36R | 0.610 |
| 1:153093537:T:A | K72M | 0.593 |
| 1:153093731:C:A | Q7H | 0.591 |
| 1:153093731:C:G | Q7H | 0.591 |
| 1:153093673:A:G | C27R | 0.574 |
dbSNP variants (sampled 300 via entrez): RS1000792713 (1:153095172 A>G), RS1000928108 (1:153095587 T>A,C), RS1002482625 (1:153095861 G>C), RS1005797130 (1:153093631 A>C,G), RS1005829807 (1:153093443 A>G,T), RS1006135779 (1:153094857 A>G,T), RS1006634349 (1:153093906 C>A,T), RS1007128450 (1:153094867 G>T), RS1007417932 (1:153096239 T>C), RS1007470211 (1:153095949 A>C), RS1007810847 (1:153095122 C>T), RS1008349732 (1:153094904 A>G), RS1008556790 (1:153093401 A>C,G), RS1009101602 (1:153096171 A>G), RS1009672045 (1:153092644 T>C)
Disease associations
OMIM: gene MIM:617588 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007564_25 | Asthma or allergic disease (pleiotropy) | 5.000000e-09 |
| GCST008916_87 | Asthma | 2.000000e-13 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenate | decreases expression, increases abundance | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| beta-Naphthoflavone | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): allergic disease, asthma